Study of the drug substances MLN0128, MLN0128+MLN1117, Weekly Paclitaxel, or the Combination of Weekly Paclitaxel and MLN0128 the Treatment of Patients with Endometrial Cancer

Update Il y a 4 ans
Reference: EUCTR2014-005394-37

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine if MLN0128 in combination with weekly paclitaxel improves progression-free survival (PFS) compared to weekly paclitaxel alone.


Inclusion criteria

  • Advanced, Recurrent, or Persistent Endometrial Cancer

Links